Change over period: —
NSE · TRUALT
TRUALT
-36.7% from the 52-week high · +5.4% above the low
TruAlt Bioenergy Ltd focuses on renewable energy solutions including biofuels, biomass, and waste-to-energy projects. The company develops and operates energy-efficient systems that reduce environmental impact while providing sustainable energy alternatives for industrial and commercial applications.
The short version. TRUALT reported revenue of ₹811 crore for Sep 2026, up 605.2% from a year earlier. Net profit was ₹35 crore. Return on equity was 6.3% in Mar 2026. Promoter holding was 71.38% in Sep 2026, up 0.83 points over 5 quarters.
1 · The price
How has the stock traded?
TRUALT trades 36.7% below its 52-week high and 5.4% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹811 cr.
37.3 pts higher than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|---|---|
| Revenue | 811 | 627 | 596 | 713 | 115 | 304 |
| Net profit | 35 | 57 | 60 | 69 | -38 | 5 |
| Net margin % | 4.3 | 9.1 | 10.1 | 9.7 | -33.0 | 1.6 |
| EPS (₹) | 4.04 | 6.67 | 6.98 | 8.09 | -4.41 | 0.6689923490335771 |
Annual
| FY2026 | |
|---|---|
| Revenue | 1728 |
| Net profit | 96 |
| Net margin % | 5.6 |
| EPS (₹) | 11.19 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 6.3% in Mar 2026; debt to equity is 1.08.
Profitability · 1 years
Returns and margins
| Mar 2026 | |
|---|---|
| Return on equity % | 6.3 |
| Return on capital % | 10.8 |
| EBITDA margin % | 20.7 |
| Net margin % | 5.3 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Up 0.83 pts over 5 quarters.
Down 0.67 pts over 5 quarters.
Up 1.29 pts over 5 quarters.
+1 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|
| Promoter | 70.55 | 70.55 | 70.55 | 70.55 | 71.38 | +0.83 |
| FII | 1.3 | 0.93 | 0.66 | 0.58 | 0.63 | -0.67 |
| DII | 7.8 | 7.27 | 9.4 | 8.36 | 9.09 | +1.29 |
| Public | 20.35 | 21.25 | 19.38 | 20.51 | 18.91 | -1.44 |
Mutual fund holdings · Oct 2026
7 schemes hold this stock
6 the month before.
- Invesco India Infrastructure Fund2.52% of NAV
- Invesco India ESG Integration Strategy Fund1.23% of NAV
- TATA INFRASTRUCTURE FUND1.04% of NAV
- Invesco India PSU Equity Fund0.88% of NAV
- TATA AGGRESSIVE HYBRID FUND0.51% of NAV
- Bandhan Small Cap Fund0.33% of NAV
- HDFC Balanced Advantage Fund0.02% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for TRUALT are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Agricultural Food & other Products stocks
Quick answers
Common questions about TRUALT
What is the TRUALT share price?
TRUALT (TRUALT) last closed at ₹334.00, down 0.86% on the day. Its 52-week range is ₹319.65 to ₹531.95.
What is the market cap of TRUALT?
TRUALT has a market capitalisation of about ₹2,892 crore. Its price-to-earnings ratio is 13.0.
How are TRUALT's latest results?
TRUALT reported revenue of ₹811 crore for Sep 2026, up 605.2% from a year earlier. Net profit was ₹35 crore. Return on equity was 6.3% in Mar 2026. Promoter holding was 71.38% in Sep 2026, up 0.83 points over 5 quarters.
Who owns TRUALT?
As of Sep 2026, shareholding was: Promoter 71.38%, FII 0.63%, DII 9.09%, Public 18.91%.
How many mutual funds hold TRUALT?
7 mutual fund schemes held TRUALT in October 2026. That compares with 6 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.